Product description
| Symbol | Cusip | Name | Amount | Value | Title Of Class | Pay of profile | |
|---|---|---|---|---|---|---|---|
| 803607100 | 803607100 | Sarepta Therapeutics Inc | 14000.0 | 1088360.0 | CORP | Long | |
| 48283N106 | 48283N106 | Kadmon Hldgs Inc | 45500.0 | 176085.0 | CORP | Long | |
| 92532F100 | 92532F100 | Vertex Pharmaceuticals Incorporated | 7250.0 | 1461817.5 | CORP | Long | |
| 61775R105 | 61775R105 | Morphic Hldg Inc | 5500.0 | 315645.0 | CORP | Long | |
| 05464T104 | 05464T104 | Axsome Therapeutics Incorporation | 12000.0 | 809520.0 | CORP | Long | |
| 48576U106 | 48576U106 | Karyopharm Therapeutics Inc | 81500.0 | 841080.0 | CORP | Long | |
| 69366J200 | 69366J200 | PTC Therapeutics, Inc. | 10000.0 | 422700.0 | CORP | Long | |
| 110122108 | 110122108 | Bristol-Myers Squibb Company | 710.0 | 47442.2 | CORP | Long | |
| 59045L106 | 59045L106 | Mersana Therapeutics Inc | 45500.0 | 617890.0 | CORP | Long | |
| 01671P100 | 01671P100 | Allakos Inc | 1400.0 | 119518.0 | CORP | Long | |
| 69242L106 | 69242L106 | Oyster Point Pharma Inc | 36500.0 | 627435.0 | CORP | Long | |
| G5269C101 | G5269C101 | Kiniksa Pharmaceuticals Ltd. | 32500.0 | 452725.0 | CORP | Long | |
| 004225108 | 004225108 | Acadia Pharmaceuticals Inc | 13500.0 | 329265.0 | CORP | Long | |
| 761330109 | 761330109 | Revance Therapeutics Inc | 6500.0 | 192660.0 | CORP | Long | |
| 74587V107 | 74587V107 | Puma Biotechnology Inc | 40000.0 | 367200.0 | CORP | Long | |
| 87808K106 | 87808K106 | Tcr2 Therapeutics Inc | 41000.0 | 672810.0 | CORP | Long | |
| 89620X506 | 89620X506 | Trillium Therapeutics Inc | 30000.0 | 291000.0 | CORP | Long | |
| 375558103 | 375558103 | Gilead Sciences, Inc. | 11800.0 | 812548.0 | CORP | Long | |
| G46188101 | G46188101 | Horizon Therapeutics Plc | 1000.0 | 93640.0 | CORP | Long | |
| N44445109 | N44445109 | Immatics N.V | 37500.0 | 435375.0 | CORP | Long | |
| 75886F107 | 75886F107 | Regeneron Pharmaceuticals, Inc. | 2050.0 | 1145007.0 | CORP | Long | |
| H0036K147 | H0036K147 | Adc Therapeutics Sa | 26000.0 | 633100.0 | CORP | Long | |
| 090572207 | 090572207 | Bio-Rad Laboratories, Inc. | 64.0 | 41234.56 | CORP | Long | |
| 09609G100 | 09609G100 | Bluebird Bio Inc | 33000.0 | 1055340.0 | CORP | Long | |
| 36118A100 | 36118A100 | Fusion Pharmaceuticals Inc | 71500.0 | 577720.0 | CORP | Long | |
| 00461U105 | 00461U105 | Aclaris Therapeutics Inc | 37000.0 | 649720.0 | CORP | Long | |
| 19240Q201 | 19240Q201 | Cogent Biosciences Inc | 122500.0 | 993475.0 | CORP | Long | |
| 00287Y109 | 00287Y109 | AbbVie Inc. | 425.0 | 47872.0 | CORP | Long | |
| 91307C102 | 91307C102 | United Therapeutics Corporation | 550.0 | 98675.5 | CORP | Long | |
| 462260100 | 462260100 | Iovance Biotherapeutics Inc | 33500.0 | 871670.0 | CORP | Long | |
| 92765F108 | 92765F108 | Viracta Therapeutics Inc | 92402.0 | 1047838.68 | CORP | Long | |
| 09062X103 | 09062X103 | Biogen Inc | 400.0 | 138508.0 | CORP | Long | |
| 874060205 | 874060205 | Takeda Pharmaceutical Company Limited | 2200.0 | 37026.0 | CORP | Long | |
| 05156V102 | 05156V102 | Aurinia Pharmaceuticals Inc | 25000.0 | 324000.0 | CORP | Long | |
| 19249H103 | 19249H103 | Coherus Biosciences Inc | 51500.0 | 712245.0 | CORP | Long | |
| 24343R106 | 24343R106 | Decibel Therapeutics Inc | 45000.0 | 387000.0 | CORP | Long | |
| 30161Q104 | 30161Q104 | Exelixis, Inc. | 20500.0 | 373510.0 | CORP | Long | |
| 45337C102 | 45337C102 | Incyte Corporation. | 4000.0 | 336520.0 | CORP | Long | |
| 89422G107 | 89422G107 | Travere Therapeutics Inc | 61500.0 | 897285.0 | CORP | Long | |
| 14888D208 | 14888D208 | Catalyst Biosciences Inc | 182500.0 | 790225.0 | CORP | Long | |
| 00653A107 | 00653A107 | Adaptimmune Therapeutics Plc | 120000.0 | 511200.0 | CORP | Long | |
| 09061G101 | 09061G101 | Biomarin Pharmaceutical Inc. | 8000.0 | 667520.0 | CORP | Long | |
| 00653Q102 | 00653Q102 | AdaptHealth Corporation | 18000.0 | 493380.0 | CORP | Long | |
| 717081103 | 717081103 | Pfizer Inc. | 2000.0 | 78320.0 | CORP | Long | |
| 00773J103 | 00773J103 | Aeglea Biotherapeutics Inc | 92500.0 | 643800.0 | CORP | Long | |
| 040047607 | 040047607 | Arena Pharmaceutic | 7500.0 | 511500.0 | CORP | Long | |
| 316175108 | 316175108 | Fidelity Institutional Cash Portfolios | 1.29 | 1.29 | RF | Long | |
| 03753U106 | 03753U106 | Apellis Pharmaceuticals Inc | 2000.0 | 126400.0 | CORP | Long | |
| 36315X101 | 36315X101 | Galapagos Nv | 21500.0 | 1481135.0 | CORP | Long | |
| 04746L104 | 04746L104 | Athira Pharma Inc | 20538.0 | 210309.12 | CORP | Long | |
| 55279B202 | 55279B202 | Mei Pharma Inc | 40000.0 | 114000.0 | CORP | Long | |
| 457669307 | 457669307 | Insmed Inc | 24000.0 | 683040.0 | CORP | Long | |
| 58933Y105 | 58933Y105 | Merck & Co., Inc | 12000.0 | 933240.0 | CORP | Long | |
| 23284P103 | 23284P103 | Cyteir Therapeutics Inc | 1000.0 | 21400.0 | CORP | Long | |
| 98978L204 | 98978L204 | Zogenix Inc | 50000.0 | 864000.0 | CORP | Long | |
| 03969K108 | 03969K108 | Arcutis Biotherapeutics Incorporation | 13500.0 | 368415.0 | CORP | Long | |
| 617760202 | 617760202 | Morphosys | 45500.0 | 875875.0 | CORP | Long | |
| 04965G109 | 04965G109 | Atreca Inc | 66500.0 | 566580.0 | CORP | Long | |
| 869367102 | 869367102 | Sutro Biopharma Inc | 27000.0 | 501930.0 | CORP | Long | |
| 46116X101 | 46116X101 | Intra-Cellular Therapies Inc | 5000.0 | 204100.0 | CORP | Long | |
| 15117B202 | 15117B202 | Celldex Therapeuti | 25000.0 | 836000.0 | CORP | Long | |
| 19459J104 | 19459J104 | Collegium Pharmaceutical Inc | 9000.0 | 212760.0 | CORP | Long |